Published in Gene Therapy Weekly, March 30th, 2000
"Pancreatic adenocarcinoma is difficult to treat and the prognosis is consequently poor," said Walter H. Gunzburg and colleagues from several universities and hospitals in Austria. "Gemcitabine was heralded as a breakthrough in the treatment of this cancer, but yet only extends life expectancy by a few months."
Gunzburg et al. presented data from their clinical trial at the conference Advances in Gene Technology: DNA, RNA, and Cancer, held in Miami, Florida, USA. The title of their presentation was "Local...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.